Top News

Merck and Moderna logos displayed on a white background

RESEARCH

16 Jan 2026

mRNA Developers Regroup After Trial Setbacks

After late-stage failures, mRNA leaders narrow pipelines, double down on vaccines and cancer, and adopt tougher capital discipline

mRNA vaccine vial on medical documents with pills, syringe, and stethoscope

MARKET TRENDS

5 Feb 2026

mRNA Deals Push the Industry Beyond Vaccines

Biotech executives mark a major corporate milestone during a Nasdaq ceremony

PARTNERSHIPS

20 Jan 2026

GSK’s $2.2B Bet Signals a New Phase in Allergy Drug Races

Latest News

MARKET TRENDS
5 Feb 2026
mRNA Deals Push the Industry Beyond Vaccines
PARTNERSHIPS
3 Feb 2026
BioNTech–CureVac Deal Marks a New Era for mRNA
PARTNERSHIPS
20 Jan 2026
GSK’s $2.2B Bet Signals a New Phase in Allergy Drug Races
INSIGHTS
19 Jan 2026
BMS–Orbital Deal Signals a Sharper Bet on In Vivo RNA

mRNA Developers Regroup After Trial Setbacks

RESEARCH

16 Jan 2026

After late-stage failures, mRNA leaders narrow pipelines, double down on vaccines and cancer, and adopt tougher capital discipline

MARKET TRENDS

6 Jun 2025

As COVID Demand Shrinks, Vaccine Makers Rethink Their Strategy

With tighter rules and a smaller market, mRNA leaders refocus on high-risk groups and aim to sharpen delivery and messaging.

3D illustration of mRNA strands representing emerging in-vivo cancer cell therapy technology

INNOVATION

2 Jun 2025

mRNA Rewrites the Rules of Cancer Cell Therapy

Myeloid's in-body mRNA tech aims to make cancer treatment faster, cheaper, and more widely available.

6 7

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.